GlassScriptPhysician profile
Reginald G Williams
NPI 1225014632
$1,223.37
in general payments reported to CMS, 2019-2025
18 companies · $183 in 2025
The $183 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $128 · 2020: $232 · 2021: $208 · 2022: $245 · 2023: $109 · 2024: $118 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $410.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $175.71 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $155.90 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $130.66 | 2019-2022 | |
| Lilly USA, LLC | $126.15 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $120.00 | 2020-2025 | Airsupra, Breztri |
| Exact Sciences Corporation | $98.42 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $69.39 | 2019-2022 | |
| Novo Nordisk INC | $60.95 | 2019-2024 | Wegovy |
| Abbvie INC. | $44.96 | 2021-2022 | |
| Pfizer INC. | $41.71 | 2020 | |
| Mylan Specialty L.P. | $38.96 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $34.14 | 2023-2024 | Rexulti, Abilify Asimtufii |
| E.R. Squibb & Sons, L.L.C. | $33.13 | 2021-2022 | |
| Amgen INC. | $26.26 | 2023 | Repatha, Otezla |
| Allergan, INC. | $20.42 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acorda Therapeutics, INC | $19.60 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.58 | 2021 | |
| Sanofi Pasteur INC. | $13.43 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reginald Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.